Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip Eftimov

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Journal of the Peripheral Nervous System : JPNS|April 12, 2019
Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathyGwen G A van Lieverloo, Luuk Wieske, Camiel Verhamme, et al.
Neuroepidemiology|July 2, 2024
Toward a Useful and Cost-Effective Workup in Chronic Polyneuropathy: The EXPRESS Study ProtocolMadde Wiersma, Gerjan M van der Star, Filip Eftimov, et al.
Rheumatology (Oxford, England)|December 7, 2021
Assessment of disability in idiopathic inflammatory myopathy: a call for linearityMinoesch Min, Anne W Walter, Johan Lim, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 21, 2021
Serum Contactin-1 in CIDP: A Cross-Sectional StudyLuuk Wieske, Lorena Martín-Aguilar, Janev Fehmi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 10, 2024
Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension studyLuis Querol, Jérôme De Sèze, Tina Dysgaard, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 23, 2021
Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosisZoë Ygj van Lierop, Luuk Wieske, Marleen Ja Koel-Simmelink, et al.
Journal of Neurology|February 14, 2022
Serum neurofilament light chain, contactin-1 and complement activation in anti-MAG IgM paraprotein-related peripheral neuropathyKarima Amaador, Luuk Wieske, Marleen J A Koel-Simmelink, et al.
Journal of the Peripheral Nervous System : JPNS|November 10, 2017
Protocol of a dose response trial of IV immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (DRIP study)Krista Kuitwaard, Willem-Jan R Fokkink, Esther Brusse, et al.
Journal of the Peripheral Nervous System : JPNS|November 2, 2017
Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathyKrista Kuitwaard, Willem-Jan R Fokkink, Esther Brusse, et al.
Journal of Neurology|June 7, 2025
Serological analysis of gluten-related antibodies in idiopathic neuropathies and cerebellar ataxiaMaxine D Rouvroye, Janna Warendorf, Alexander Vrancken, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Journal of the Peripheral Nervous System : JPNS|April 12, 2019
Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathyGwen G A van Lieverloo, Luuk Wieske, Camiel Verhamme, et al.
Neuroepidemiology|July 2, 2024
Toward a Useful and Cost-Effective Workup in Chronic Polyneuropathy: The EXPRESS Study ProtocolMadde Wiersma, Gerjan M van der Star, Filip Eftimov, et al.
Rheumatology (Oxford, England)|December 7, 2021
Assessment of disability in idiopathic inflammatory myopathy: a call for linearityMinoesch Min, Anne W Walter, Johan Lim, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 21, 2021
Serum Contactin-1 in CIDP: A Cross-Sectional StudyLuuk Wieske, Lorena Martín-Aguilar, Janev Fehmi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 10, 2024
Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension studyLuis Querol, Jérôme De Sèze, Tina Dysgaard, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 23, 2021
Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosisZoë Ygj van Lierop, Luuk Wieske, Marleen Ja Koel-Simmelink, et al.
Journal of Neurology|February 14, 2022
Serum neurofilament light chain, contactin-1 and complement activation in anti-MAG IgM paraprotein-related peripheral neuropathyKarima Amaador, Luuk Wieske, Marleen J A Koel-Simmelink, et al.
Journal of the Peripheral Nervous System : JPNS|November 10, 2017
Protocol of a dose response trial of IV immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (DRIP study)Krista Kuitwaard, Willem-Jan R Fokkink, Esther Brusse, et al.
Journal of the Peripheral Nervous System : JPNS|November 2, 2017
Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathyKrista Kuitwaard, Willem-Jan R Fokkink, Esther Brusse, et al.
Journal of Neurology|June 7, 2025
Serological analysis of gluten-related antibodies in idiopathic neuropathies and cerebellar ataxiaMaxine D Rouvroye, Janna Warendorf, Alexander Vrancken, et al.
Pageof 10